Regulatory PathRegulatory requirements compared

Active substances

Guaifenesin + Pseudoephedrine + Triprolidine

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
RINOFED EXPECTORANT SYRUP 100 ML20,6,0.25 mg/ml,mg/ml,mg/mlSyrup · Oral use1 BottleSAR 7.30Generic · OTCJazeera Pharmaceutical Industries (JPI)Valid
TRIPOFED EXPECTORANT SYRUP20,6,0.25 mg/ml,mg/ml,mg/mlSyrup · Oral use1 BottleSAR 7.30Generic · OTCKUWAIT SAUDI PHARMACEUTICAL INDUSTRIESValid
ACTIFED EXPECTORANT SYRUP0.25, 6, 20 mg/mlSyrup · Oral use1 BottleSAR 6.60Generic · OTCGLAXO SAUDI ARABIAWithdrawn by MAH · Not Marketed
PECTOMED EXPECTORANT SYRUP20,6,0.25 mg/ml,mg/ml,mg/mlSyrup · Oral use1 BottleSAR 5.50Generic · OTCMEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIESWithdrawn by MAH · Not Marketed
UNIFED EXPECTORANT SYRUP20,6,0.25 mg/ml,mg/ml,mg/mlSyrup · Oral use1 BottleSAR 5.10Generic · OTCUNITED PHARMACEUTICAL CO.Withdrawn by MAH · Not Marketed

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.